Breaking News Instant updates and real-time market news.

GE

General Electric

$18.76

-0.26 (-1.37%)

06:39
01/16/18
01/16
06:39
01/16/18
06:39

GE Capital to fund contributions, suspend dividend to GE for forseeable future

GE Capital to fund contributions and suspend dividend to GE for foreseeable future. Ongoing actions over the next two years to make GE Capital smaller, more focused and restore its capital ratios to appropriate levels. Goodwill and other non-cash impairments of $1.8 billion after-tax related to GE Capital actions. No impact to Industrial business and 2018 capital allocation plan.

  • 24

    Jan

GE General Electric
$18.76

-0.26 (-1.37%)

12/13/17
DBAB
12/13/17
NO CHANGE
DBAB
Sell
Deutsche concerned Ed Garden won't stay long on GE board
If Trian were to significantly reduce its ownership stake in General Electric in the coming year, from just the 80 basis points of shares it owns now, Ed Garden would likely be forced to step down from the company's board, Deutsche Bank analyst John Inch tells investors in a research note titled "GE Board risk." The analyst believes Trian could realize incremental pressure to reduce or exit its GE position, especially if the stock, as Inch expects, struggles to gain upward traction. Garden leaving the board would create "substantial headline risk," particularly given the public vote of confidence that new GE CEO John Flannery has placed in him, the analyst contends. As such, Inch sees risk that Garden may not end up serving on GE's Board over the long term. The analyst believes his selection to the board raises some questions given Trian's relatively small stake in GE. Were there not other equally qualified candidates with more prospective longevity for the position versus a hedge fund executive whose firm owns just 80 basis points of the stock, Inch asks. The analyst keeps a Sell rating on GE with a $15 price target. The shares closed yesterday up 26c to $17.97.
12/21/17
DBAB
12/21/17
NO CHANGE
Target $15
DBAB
Sell
GE could exit Baker Hughes in 2018, says Deutsche Bank
Deutsche Bank analyst John Inch believes General Electric (GE) could exit its 62.5% ownership of Baker Hughes (BHGE) sometime in 2018. The eventual monetization and separation of GE's entire oil and gas portfolio would be consistent with management's signaling regarding its investment in Baker Hughes, Inch tells investors in a research note. GE's exit timing may not be optimal, however, considering that the pickup in industry activity is likely to continue given improved energy prices, the analyst contends. He adds that GE would forego $188M of dividend from Baker Hughes and any future additional share repurchase benefit by the company. Inch has a Sell rating on GE with a $15 price target.
01/08/18
JPMS
01/08/18
NO CHANGE
Target $16
JPMS
Underweight
JPMorgan sees 'too many risks,' cuts GE price target to $16
JPMorgan analyst C. Stephen Tusa says he sees "too many risks" to change his view on shares of General Electric. The analyst keeps an Underweight rating on the name and cut his price target for the stock to $16 from $17. There is no other company in the sector where earnings and free cash expectations were cut by 50% last year, Tusa tells investors in a research note. GE's leverage remains high and one-third of its core business lacks a "credible turnaround plan in the face of a dramatic fundamental shift," Tusa writes.
01/12/18
JPMS
01/12/18
NO CHANGE
JPMS
Underweight
GE management changes 'red flags for ongoing concern,' says JPMorgan
The recently announced departures of key executives at General Electric, namely Joe Mastrangelo, CEO of Gas Power Systems this week, and Rich Laxer CEO of GE Capital in late December, should not be overlooked, JPMorgan analyst C. Stephen Tusa tells investors in a research note. The departures are "further red flags around the uncertainties that remain" and for the company's "ongoing concern," Tusa contends. The analyst continues to think that calls for a bottom based "merely on stock price continue to ignore the fundamental realities at play" relating to GE's leverage, "weak" free cash flow, and "challenged" businesses like Power. Tusa thinks "there are still shoes to drop." He keeps an Underweight rating on General Electric.

TODAY'S FREE FLY STORIES

ARWR

Arrowhead

$16.02

(0.00%)

09:41
07/23/18
07/23
09:41
07/23/18
09:41
Recommendations
Arrowhead analyst commentary  »

Arrowhead fair value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNC

Tronc

$16.21

(0.00%)

09:41
07/23/18
07/23
09:41
07/23/18
09:41
Periodicals
Tronc seen making 'massive' layoffs at Daily News, NY Post reports »

The Daily News, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$10.85

(0.00%)

, HAS

Hasbro

$94.02

(0.00%)

09:40
07/23/18
07/23
09:40
07/23/18
09:40
Options
Unusually active option classes on open July 23rd »

Unusual total active…

HCLP

Hi-Crush Partners

$10.85

(0.00%)

HAS

Hasbro

$94.02

(0.00%)

DLTR

Dollar Tree

$86.45

(0.00%)

HPE

HP Enterprise

$15.47

(0.00%)

IBB

iShares Nasdaq Biotechnology Index

$118.23

(0.00%)

HAL

Halliburton

$45.23

(0.00%)

RHT

Red Hat

$147.89

(0.00%)

XLF

Financial Select Sector

$27.57

(0.00%)

BMY

Bristol-Myers

$56.71

(0.00%)

TSLA

Tesla

$313.49

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 01

    Aug

  • 01

    Aug

  • 01

    Aug

  • 07

    Aug

  • 08

    Aug

CHFS

CHF Solutions

$1.50

0.01 (0.67%)

09:38
07/23/18
07/23
09:38
07/23/18
09:38
Hot Stocks
CHF Solutions shares rise in early trade after VA contract circulated »

Shares of CHF Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPLO

Diplomat Pharmacy

$22.35

-2.575 (-10.33%)

09:35
07/23/18
07/23
09:35
07/23/18
09:35
Recommendations
Diplomat Pharmacy analyst commentary  »

Diplomat Pharmacy recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

09:35
07/23/18
07/23
09:35
07/23/18
09:35
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

09:35
07/23/18
07/23
09:35
07/23/18
09:35
General news
U.S. existing home sales preview: »

U.S. existing home sales…

UGP

Ultrapar

$11.42

0.375 (3.40%)

09:33
07/23/18
07/23
09:33
07/23/18
09:33
Downgrade
Ultrapar rating change  »

Ultrapar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZZ

Cosan

$8.32

0.105 (1.28%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Downgrade
Cosan rating change  »

Cosan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$45.23

0.26 (0.58%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton says expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LPNT

LifePoint

$47.85

-0.75 (-1.54%)

, CYH

Community Health

$2.72

-0.055 (-1.99%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Recommendations
LifePoint, Community Health, Apollo Global, HCA Healthcare analyst commentary  »

Deal activity could pick…

LPNT

LifePoint

$47.85

-0.75 (-1.54%)

CYH

Community Health

$2.72

-0.055 (-1.99%)

APO

Apollo Global

$35.39

-0.22 (-0.62%)

HCA

HCA Healthcare

$108.01

0.31 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Jul

  • 27

    Jul

  • 02

    Aug

  • 22

    Aug

BIDU

Baidu

$260.00

-2.32 (-0.88%)

09:31
07/23/18
07/23
09:31
07/23/18
09:31
Downgrade
Baidu rating change  »

Baidu downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 10

    Sep

SLM

Sallie Mae

$11.71

-0.11 (-0.93%)

, CHGG

Chegg

$29.07

-0.07 (-0.24%)

09:31
07/23/18
07/23
09:31
07/23/18
09:31
Hot Stocks
Sallie Mae, Chegg introduce enhanced Study Starter benefit »

Sallie Mae (SLM) and…

SLM

Sallie Mae

$11.71

-0.11 (-0.93%)

CHGG

Chegg

$29.07

-0.07 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

09:30
07/23/18
07/23
09:30
07/23/18
09:30
Hot Stocks
Trump calls U.S. Post Office Amazon's 'delivery boy' at fraction of cost »

President Trump tweeted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

HAL

Halliburton

$45.23

0.26 (0.58%)

09:29
07/23/18
07/23
09:29
07/23/18
09:29
Hot Stocks
Halliburton says sees international business better in 2H18 »

Says seeing ramp up in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

BV

BrightView

$21.95

0.14 (0.64%)

09:29
07/23/18
07/23
09:29
07/23/18
09:29
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$45.23

0.26 (0.58%)

09:28
07/23/18
07/23
09:28
07/23/18
09:28
Hot Stocks
Halliburton says sees Q3 effective tax rate approximately 20% »

Says expects go generate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

BSX

Boston Scientific

$33.77

0.06 (0.18%)

, SYK

Stryker

$174.33

1.44 (0.83%)

09:26
07/23/18
07/23
09:26
07/23/18
09:26
Recommendations
Boston Scientific, Stryker analyst commentary  »

Boston Scientific price…

BSX

Boston Scientific

$33.77

0.06 (0.18%)

SYK

Stryker

$174.33

1.44 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 14

    Aug

  • 15

    Aug

HAS

Hasbro

$94.02

0.38 (0.41%)

09:26
07/23/18
07/23
09:26
07/23/18
09:26
Hot Stocks
Hasbro says 30% of manufacturing is outside of China »

Says biggest percentage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

BV

BrightView

$21.95

0.14 (0.64%)

09:23
07/23/18
07/23
09:23
07/23/18
09:23
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

, AUDVF

Audi AG

$0.00

(0.00%)

09:22
07/23/18
07/23
09:22
07/23/18
09:22
Periodicals
VW board member wary of 'humiliating' Audi's Stadler, FT reports »

Hiltrud Werner, a top…

VLKAY

Volkswagen

$0.00

(0.00%)

AUDVF

Audi AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$33.77

0.06 (0.18%)

09:21
07/23/18
07/23
09:21
07/23/18
09:21
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 14

    Aug

  • 15

    Aug

HAL

Halliburton

$45.23

0.26 (0.58%)

09:21
07/23/18
07/23
09:21
07/23/18
09:21
Earnings
Halliburton says sees Q3 earnings 'similar' to Q2 »

Says temporary challenges…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

09:20
07/23/18
07/23
09:20
07/23/18
09:20
General news
U.S. Sentiment Strength Extends into July: »

U.S. Sentiment Strength…

MU

Micron

$55.01

-1.2 (-2.13%)

, QCOM

Qualcomm

$58.62

-0.7 (-1.18%)

09:19
07/23/18
07/23
09:19
07/23/18
09:19
Recommendations
Micron, Qualcomm, AMD, Intel, Nvidia, Microchip, Texas Instruments, Marvell, Analog Devices, Cypress Semiconductor analyst commentary  »

Tariff uncertainty a…

MU

Micron

$55.01

-1.2 (-2.13%)

QCOM

Qualcomm

$58.62

-0.7 (-1.18%)

AMD

AMD

$16.49

-0.22 (-1.32%)

INTC

Intel

$51.92

-0.09 (-0.17%)

NVDA

Nvidia

$250.87

-1.15 (-0.46%)

MCHP

Microchip

$94.39

-0.46 (-0.48%)

TXN

Texas Instruments

$114.99

0.34 (0.30%)

MRVL

Marvell

$21.85

0.14 (0.64%)

ADI

Analog Devices

$97.81

-0.46 (-0.47%)

CY

Cypress Semiconductor

$17.06

-0.09 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 07

    Aug

  • 14

    Aug

  • 16

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.